National Science Library, Chinese Academy of Sciences
  登录 机构网站 ENGLISH
您当前的位置是:首页->检索结果浏览
排序:
全选
显示: 条结果
1    
Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcin... 期刊论文

The Lancet Oncology     ISSN:1470-2045  Volume:18  Issue:12  Page:1624-1636  

Vilgrain Valérie;   Pereira Helena;   Assenat Eric;   Guiu Boris;   Ilonca Alina Diana;   ...

来源数据库: [Web of Science, Scopus],

被引频次:98

文摘信息 获取全文 问图书馆员

2    
Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial 期刊论文

Lancet, The     ISSN:0140-6736  Volume:384  Issue:9940  Page:319-328  

Brose Marcia S Dr;   Nutting Christopher M Prof;   Jarzab Barbara Prof;   Elisei Rossella Prof;   Siena Salvatore MD;   ...

来源数据库: [Web of Science, Science Database],

被引频次:503

文摘信息 获取全文 问图书馆员

3    
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial 期刊论文

Lancet, The     ISSN:0140-6736  Volume:389  Issue:10064  Page:56-66  

Bruix Jordi Dr;   Qin Shukui Prof;   Merle Philippe Prof;   Granito Alessandro MD;   Huang Yi-Hsiang Prof;   ...

来源数据库: [Web of Science, Scopus, Science Database],

被引频次:642

文摘信息 获取全文 问图书馆员

4    
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial 期刊论文

The Lancet     ISSN:0140-6736  Volume:391  Issue:10126  Page:1163-1173  

Kudo Masatoshi;   Finn Richard S;   Qin Shukui;   Han Guohong;   Han Kwang-Hyub;   ...

来源数据库: [Web of Science, Scopus, Science Database],

被引频次:276

文摘信息 获取全文 问图书馆员

5    
Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial 期刊论文

Lancet Oncology, The     ISSN:1470-2045  Volume:16  Issue:13  Page:1344-1354  

Bruix Jordi Prof;   Takayama Tadatoshi Prof;   Mazzaferro Vincenzo Prof;   Chau Gar-Yang Prof;   Yang Jiamei Prof;   ...

来源数据库: [Web of Science, Scopus],

被引频次:287

文摘信息 获取全文 问图书馆员

6    
Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial 期刊论文

Lancet, The     ISSN:0140-6736  Volume:387  Issue:10032  Page:2008-2016  

Haas Naomi B Dr;   Manola Judith MS;   Uzzo Robert G Prof;   Flaherty Keith T MD;   Wood Christopher G Prof;   ...

来源数据库: [MEDLINE, Scopus, Science Database],

文摘信息 获取全文 问图书馆员

7    
Loss of NAD Homeostasis Leads to Progressive and Reversible Degeneration of Skeletal Muscle 期刊论文

Cell Metabolism     ISSN:1550-4131  Volume:24  Issue:2  Page:269-282  

Frederick David W;   Loro Emanuele;   Liu Ling;   Davila Antonio;   Chellappa Karthikeyani;   ...

来源数据库: [Web of Science, Scopus],

被引频次:74

文摘信息 获取全文 问图书馆员

8    
Management of hepatocellular carcinoma: An update 期刊论文

Hepatology     ISSN:0270-9139  Volume:53  Issue:3  Page:1020-1022  

Bruix Jordi;   Sherman Morris;  

来源数据库: [Web of Science, Scopus],

被引频次:4881

获取全文 问图书馆员

9    
Axitinib versus sorafenib as second-line treatment for advanced renal cell carcinoma: overall survival analysis and updated results from a randomised phase 3 trial 期刊论文

Lancet Oncology, The     ISSN:1470-2045  Volume:14  Issue:6  Page:552-562  

Motzer Robert J Dr;   Escudier Bernard MD;   Tomczak Piotr MD;   Hutson Thomas E DO;   Michaelson M Dror MD;   ...

来源数据库: [Web of Science, Scopus],

被引频次:400

文摘信息 获取全文 问图书馆员

10    
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial 期刊论文

Journal of Hepatology     ISSN:0168-8278  Volume:57  Issue:4  Page:821-829  

Bruix Jordi;   Raoul Jean-Luc;   Sherman Morris;   Mazzaferro Vincenzo;   Bolondi Luigi;   ...

来源数据库: [Web of Science, Scopus],

被引频次:406

文摘信息 获取全文 问图书馆员

< 首页 < 上一页 1 2 3 4 5 下一页 >
导出参考文献:×
作者信息:×